MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MREO has $45,917K in assets. $5,001K in debts. $40,992K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1046.49%
Quick Ratio
1046.49%
Cash Ratio
952.86%
Debt to Asset Ratio
10.89%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Research and development incenti...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
40,992
Prepaid expenses and other current assets
2,531
Research and development incentives receivables
1,497
Total current assets
45,020
Property and equipment, at cost
1,222
Less accumulated depreciation
1,085
Property and equipment, net
137
Operating lease right-of-use assets, net
244
Intangible assets, net
516
Total assets
45,917
Accounts payable
1,333
Accrued expenses
2,026
Convertible loan notes - current
0
Operating lease liabilities - current
202
Other current liabilities
741
Total current liabilities
4,302
Warrant liabilities - non current
38
Operating lease liabilities- non current
0
Other non-current liabilities
661
Total liabilities
5,001
Ordinary shares, par value 0.003 per share 795,658,504 shares issued at december 31, 2025 (december 31, 2024 775,728,034)
3,135
Additional paid-in capital
549,622
Accumulated deficit
-501,018
Accumulated other comprehensive loss
-10,823
Total shareholders' equity
40,916
Total liabilities and shareholders' equity
45,917
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$40,992K Prepaid expenses andother current assets$2,531K Research and developmentincentives receivables$1,497K Property and equipment,at cost$1,222K Total current assets$45,020K Intangible assets, net$516K Operating leaseright-of-use assets, net$244K Property and equipment,net$137K Less accumulateddepreciation$1,085K Total assets$45,917K Total liabilities andshareholders' equity$45,917K Total shareholders'equity$40,916K Total liabilities$5,001K Accumulated deficit-$501,018K Accumulated othercomprehensive loss-$10,823K Additional paid-in capital$549,622K Total currentliabilities$4,302K Other non-currentliabilities$661K Warrant liabilities -non current$38K Ordinary shares, parvalue 0.003 per share...$3,135K Accrued expenses$2,026K Accounts payable$1,333K Other currentliabilities$741K Operating leaseliabilities - current$202K

Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group plc (MREO)